WO2026003663 - SKIN FLAP MANAGEMENT FOR MEDICAL DEVICES HAVING A TRANSCUTANEOUS LINK
National phase entry is expected:
Publication Number
WO/2026/003663
Publication Date
02.01.2026
International Application No.
PCT/IB2025/056235
International Filing Date
19.06.2025
Title **
[English]
SKIN FLAP MANAGEMENT FOR MEDICAL DEVICES HAVING A TRANSCUTANEOUS LINK
[French]
GESTION DES LAMBEAUX CUTANÉS POUR DISPOSITIFS MÉDICAUX AYANT UNE LIAISON TRANSCUTANÉE
Applicants **
COCHLEAR LIMITED
Inventors
ANDERSSON, Peter
Priority Data
63/664,075
25.06.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
MOIP
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2636 | |
| EPO | Filing, Examination, Granting | 19613 | |
| Japan | Filing, Examination, Granting | 2625 | |
| South Korea | Filing, Examination, Granting | 2278 | |
| USA | Filing, Examination, Granting | 7340 |
Total:
34,492
Contact Us
Abstract[English]
Methods and systems for evaluating tissue health of a recipient comprising receiving a measuring command at a sensor comprising at least one light emitting diode (LED) and a light detector are disclosed. The method further comprises emitting one or more light beams from the at least one LED in a direction of a medical device wherein the medical device is implanted subcutaneously or percutaneously in the recipient. The light detector receives one or more reflected light beams. The intensity of the reflected light beams from the light detector is measured and is used to determine an oxygen saturation value.[French]
L'invention concerne des procédés et des systèmes d'évaluation de la santé tissulaire d'un receveur consistant à recevoir une commande de mesure à un capteur comprenant au moins une diode électroluminescente (DEL) et un détecteur de lumière. Le procédé consiste en outre à émettre un ou plusieurs faisceaux lumineux à partir de la ou des DEL dans une direction d'un dispositif médical, le dispositif médical étant implanté de manière sous-cutanée ou percutanée dans le receveur. Le détecteur de lumière reçoit un ou plusieurs faisceaux lumineux réfléchis. L'intensité des faisceaux lumineux réfléchis provenant du détecteur de lumière est mesurée et est utilisée pour déterminer une valeur de saturation en oxygène.